Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

True histiocytic lymphoma.

E G Levine1, C A Hanson, W Jaszcz

  • 1Department of Medicine and Laboratory Medicine, University of Minnesota, Minneapolis.

Seminars in Oncology
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response.

Blood cancer journal·2022
Same author

Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients.

Blood cancer journal·2018
Same author

A pilot investigation on impact of participation in a long-term follow-up clinic (LTFU) on breast cancer and cardiovascular screening among women who received chest radiation for Hodgkin lymphoma.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2018
Same author

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients.

Blood cancer journal·2017
Same author

Chemical looping of metal nitride catalysts: low-pressure ammonia synthesis for energy storage.

Chemical science·2017
Same author

Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis.

Leukemia·2017
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Accurate diagnosis of T-cell histiocytic lymphoma (THL) requires specific markers, as clinical and histopathological features are often nonspecific. Current treatment for THL mirrors that of diffuse large cell lymphoma, with curability data pending further research.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • T-cell histiocytic lymphoma (THL) presents diagnostic challenges due to nonspecific clinical and histopathological features.
  • Clinical presentation often mimics intermediate-grade lymphomas, making differentiation difficult without specific markers.
  • Histopathological findings alone are insufficient to confirm THL, necessitating further diagnostic investigations.

Purpose of the Study:

  • To highlight the diagnostic difficulties in T-cell histiocytic lymphoma (THL).
  • To emphasize the necessity of incorporating specific cytochemical and immunologic markers for accurate THL diagnosis.
  • To discuss current treatment approaches and the need for further research into THL characteristics and curability.

Main Methods:

  • Review of clinical and histopathological data for T-cell histiocytic lymphoma (THL) cases.

Related Experiment Videos

  • Analysis of diagnostic criteria, focusing on the role of specific markers.
  • Comparison of THL presentation and treatment with other lymphoma types.

    • Main Results:

    • Clinical findings in THL are nonspecific and often resemble intermediate-grade lymphomas.
    • Histopathological features suggest a histiocytic origin but require specific markers for definitive diagnosis.
    • Detection of specific histiocytic markers is crucial for establishing a THL diagnosis, especially when lymphoid origin is unclear.

    Conclusions:

    • Accurate diagnosis of THL is hindered by nonspecific clinical and histopathological findings.
    • The integration of cytochemical and immunologic markers is essential to prevent misdiagnosis of THL.
    • Current treatment for THL aligns with diffuse large cell lymphoma protocols, but long-term outcomes and curability require further investigation.